Most patients undergo ERCP to diagnose pancreatic and bile ducts which act as passageways for bowel movement, and treat complications in the gall bladder, bile duct and pancreas. However, 10-15% of these patients are at risk of post-ERCP Pancreatitis (PEP).
Continue reading →